bluebird bio Inc (NAS:BLUE)
$ 0.405 0.0272 (7.2%) Market Cap: 78.75 Mil Enterprise Value: 376.50 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 31/100

Q2 2024 bluebird bio Inc Earnings Call Transcript

Aug 14, 2024 / 12:00PM GMT
Release Date Price: $0.8149 (-23.12%)
Operator

Thank you for standing by. My name is Ken and I will be your conference operator today. At this time, I would like to welcome everyone to the bluebird bio second quarter 2024 results call. (Operator Instructions)

I would now like to turn the conference over to Courtney O'Leary from Investor Relations. You may begin.

Courtney O;Leary
bluebird bio Inc - Investor Relations

' -

Good morning, everyone, and thank you for joining our second quarter 2024 results call today. My name is Courtney O'Leary, Director of Investor Relations at bluebird bio.

Before we begin, let me review our Safe Harbor Statement. Today's discussion contains statements that are forward-looking under the Private Securities Litigation Reform Act of 1995, including expectations regarding our future financial results and financial position, in addition to statements of the company's plans, expectations or intentions regarding regulatory progress, commercialization plans and business operations.

Such statements are based on current expectations and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot